Cumberland Pharmaceuticals Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $9.53 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2020-05-22
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2020-03-31 was $9.53K.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-09-30 was $13.27K, a 36.75% decline year-over-year.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-06-30 was $17.30K, a 30.11% decline year-over-year.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$33.46K, a 358.38% decline year-over-year.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2020-03-31 | $9.53K 10-Q · filed 2020-05-22 | ||
| 2019-09-30 | $13.27K 10-Q · filed 2019-11-13 | $30.57K derived: sum of 2 quarters · filed 2019-11-13 | -$2.89K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $17.30K 10-Q · filed 2019-08-14 | -$16.16K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$33.46K 10-Q · filed 2020-05-22 | ||
| 2018-09-30 | $20.98K 10-Q · filed 2019-11-13 | $45.74K derived: sum of 2 quarters · filed 2019-11-13 | $58.69K 10-Q · filed 2019-11-13 |
| 2018-06-30 | $24.76K 10-Q · filed 2019-08-14 | $37.71K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $12.95K 10-Q · filed 2019-05-15 | ||
| 2017-09-30 | $14.21K 10-Q · filed 2018-11-14 | $30.80K derived: sum of 2 quarters · filed 2018-11-14 | $49.92K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $16.59K 10-Q · filed 2018-08-14 | $35.71K 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $19.12K 10-Q · filed 2018-05-09 | ||
| 2016-09-30 | $10.68K 10-Q · filed 2017-11-08 | $23.57K derived: sum of 2 quarters · filed 2017-11-08 | $39.02K 10-Q · filed 2017-11-08 |
| 2016-06-30 | $12.89K 10-Q · filed 2017-08-09 | $28.34K 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $15.45K 10-Q · filed 2017-05-15 | ||
| 2015-09-30 | $4.91K 10-Q · filed 2016-11-03 | $16.61K derived: sum of 2 quarters · filed 2016-11-03 | $37.78K 10-Q · filed 2016-11-03 |
| 2015-06-30 | $11.70K 10-Q · filed 2016-08-05 | $31.47K 10-Q · filed 2016-08-05 | |
| 2015-03-31 | $19.77K 10-Q · filed 2016-05-13 | ||
| 2014-09-30 | $16.74K 10-Q · filed 2015-11-06 | $29.77K derived: sum of 2 quarters · filed 2015-11-06 | $40.91K 10-Q · filed 2015-11-06 |
| 2014-06-30 | $13.03K 10-Q · filed 2015-08-07 | $24.17K 10-Q · filed 2015-08-07 | |
| 2014-03-31 | $11.14K 10-Q · filed 2015-05-15 | ||
| 2013-09-30 | $12.55K 10-Q · filed 2014-11-07 | $35.77K 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |